CG Oncology
Jee-Hyun Kim, PhD has a diverse work experience spanning from 2005 to present. Currently, Jee-Hyun Kim serves as the Associate Director of Clinical Operations at CG Oncology, starting in January 2022. In this role, Jee-Hyun Kim is responsible for overseeing clinical protocols, managing a Phase 2 clinical trial, ensuring compliance with guidelines and regulations, managing study vendors, and providing strategic input in biomarker analysis.
Prior to this, Jee-Hyun Kim worked at SillaJen Inc. as a Clinical Operations Manager from June 2017 to February 2020. At SillaJen Inc., Jee-Hyun Kim gained valuable experience in clinical operations management.
From 2014 to 2017, Jee-Hyun Kim worked at PAREXEL in various roles, including Project Manager, Associate Project Manager, and Enrollment Specialist I. In these positions, Jee-Hyun Kim managed clinical projects, maintained budgets, managed vendors, coordinated participant enrollment, and developed recruitment strategies.
Before joining the industry, Jee-Hyun Kim pursued postdoctoral research at the University of Southern California from November 2012 to December 2014. Jee-Hyun Kim also worked as a Postdoctoral Research Associate and Graduate Student at Weill Cornell Medical College from 2012 to 2012 and from 2006 to 2012 respectively. Early in their career, Jee-Hyun Kim gained research experience as a Research Assistant at Yonsei University College of Medicine from 2005 to 2006.
Overall, Jee-Hyun Kim's work experience demonstrates a strong background in clinical operations, project management, and research in various academic and industry settings.
Jee-Hyun Kim, PhD pursued their education in a chronological order. Jee-Hyun started their academic journey in 2001 at Yonsei University, where they obtained a Bachelor of Science (B.S.) degree in Biotechnology in 2005. During this time, in 2003-2004, they also participated in an Education Abroad Exchange Program at UC San Diego, focusing on Biology, General.
In 2006, Jee-Hyun Kim joined the Joan & Sanford I. Weill Medical College of Cornell University, where they pursued their doctoral studies. Jee-Hyun successfully completed their Doctor of Philosophy (Ph.D.) degree in Microbiology and Immunology in 2012.
Furthermore, Jee-Hyun Kim obtained a Certificate in Biotechnology Project Management from the University of Washington in March 2016.
This person is not in any offices
CG Oncology
1 followers
CG Oncology is a clinical-stage biotechnology company focused on developing the next evolution of oncolytic immunotherapy for patients with advanced cancer.